BDTBOTCServices-Management Consulting ServicesFiscal year ends September 30

Bodhi Tree Biotechnology Inc

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$0.28+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $7.17M
P/E (TTM): –
Dividend yield: –

Bodhi Tree Biotechnology Inc income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-09-30
Revenue	0.02
General & Administrative	0.16
Operating Income	-0.15
Other Non-Operating Income	0.00
Pretax Income	-0.15
Income Tax Expense	0.00
Net Income incl. Noncontrolling Interests	-0.15
Net Income	-0.15
EPS (Basic)(per share)	-0.01
EPS (Diluted)(per share)	-0.01
Shares Outstanding (Basic, Weighted)(shares)	25
Shares Outstanding (Diluted, Weighted)(shares)	25
Net Interest Income	0.00

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -310.2%
Net margin: -313.6%
Return on equity, FY2025: -77.1%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 88.6%

Valuation

P/E ratio: –
Price to sales: 193.90
Price to book: 519.02
Dividend yield: –